Prospective Cohort Study on the Effectiveness of Influenza and Pneumococcal Vaccines in Preventing Pneumonia Development and Hospitalization
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Joon Young | - |
dc.contributor.author | Lee, Jin Soo | - |
dc.contributor.author | Wie, Seong-Heon | - |
dc.contributor.author | Kim, Hyo Youl | - |
dc.contributor.author | Lee, Jacob | - |
dc.contributor.author | Bin Seo, Yu | - |
dc.contributor.author | Jeong, Hye Won | - |
dc.contributor.author | Kim, Shin Woo | - |
dc.contributor.author | Lee, Sun Hee | - |
dc.contributor.author | Park, Kyung-Hwa | - |
dc.contributor.author | Noh, Ji Yun | - |
dc.contributor.author | Choi, Won Suk | - |
dc.contributor.author | Cheong, Hee Jin | - |
dc.contributor.author | Kim, Woo Joo | - |
dc.date.accessioned | 2021-09-04T19:36:52Z | - |
dc.date.available | 2021-09-04T19:36:52Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015-02 | - |
dc.identifier.issn | 1556-6811 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94511 | - |
dc.description.abstract | Pneumonia and acute exacerbation of chronic illness are leading causes of influenza-related hospitalization. Therefore, influenza and pneumococcal vaccinations are strongly recommended for adults with comorbidities. Using a hospital-based influenza surveillance system, we performed a multicenter, prospective cohort study of patients visiting emergency rooms with influenza-like illness (ILI) during the influenza epidemic period in 2013 to 2014. Patients aged >= 19 years were enrolled, and clinical data were collected. Multivariate analyses were performed to estimate the effectiveness of influenza and pneumococcal vaccination in preventing pneumonia development and hospitalization. During study periods, 2,262 patients with ILI were registered. Among 2,217 patients with available vaccination records, 31.9% (707 patients) and 9.7% (216 patients) had received influenza and pneumococcal vaccines, respectively. Among patients who had been administered a pneumococcal vaccine, 94.4% had received the 23-valent polysaccharide vaccine (PPV23). The adjusted rates of effectiveness of the influenza vaccine for preventing pneumonia development and hospitalization were 64.0% (95% confidence interval [CI] = 29% to 81%) and 35.0% (95% CI = 12% to 52%), respectively. Pneumococcal vaccination did not reduce pneumonia development or hospitalization. In conclusion, influenza rather than PPV23 vaccination may reduce pneumonia development and hospitalization in patients with preceding ILI. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER SOC MICROBIOLOGY | - |
dc.subject | LABORATORY-CONFIRMED INFLUENZA | - |
dc.subject | RESPIRATORY SYNCYTIAL VIRUS | - |
dc.subject | BACTERIAL PNEUMONIA | - |
dc.subject | ELDERLY PERSONS | - |
dc.subject | OLDER-ADULTS | - |
dc.subject | VACCINATION | - |
dc.subject | SEASONS | - |
dc.subject | KOREA | - |
dc.subject | SURVEILLANCE | - |
dc.subject | DISEASE | - |
dc.title | Prospective Cohort Study on the Effectiveness of Influenza and Pneumococcal Vaccines in Preventing Pneumonia Development and Hospitalization | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Joon Young | - |
dc.contributor.affiliatedAuthor | Noh, Ji Yun | - |
dc.contributor.affiliatedAuthor | Choi, Won Suk | - |
dc.contributor.affiliatedAuthor | Kim, Woo Joo | - |
dc.identifier.doi | 10.1128/CVI.00673-14 | - |
dc.identifier.scopusid | 2-s2.0-84921985073 | - |
dc.identifier.wosid | 000348772200012 | - |
dc.identifier.bibliographicCitation | CLINICAL AND VACCINE IMMUNOLOGY, v.22, no.2, pp.229 - 234 | - |
dc.relation.isPartOf | CLINICAL AND VACCINE IMMUNOLOGY | - |
dc.citation.title | CLINICAL AND VACCINE IMMUNOLOGY | - |
dc.citation.volume | 22 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 229 | - |
dc.citation.endPage | 234 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.subject.keywordPlus | LABORATORY-CONFIRMED INFLUENZA | - |
dc.subject.keywordPlus | RESPIRATORY SYNCYTIAL VIRUS | - |
dc.subject.keywordPlus | BACTERIAL PNEUMONIA | - |
dc.subject.keywordPlus | ELDERLY PERSONS | - |
dc.subject.keywordPlus | OLDER-ADULTS | - |
dc.subject.keywordPlus | VACCINATION | - |
dc.subject.keywordPlus | SEASONS | - |
dc.subject.keywordPlus | KOREA | - |
dc.subject.keywordPlus | SURVEILLANCE | - |
dc.subject.keywordPlus | DISEASE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.